{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:50:17Z","timestamp":1791039017471,"version":"4.1.0"},"reference-count":99,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":2216,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>:<\/jats:bold>The etiology of Parkinson's disease is not known. Nevertheless a significant body of biochemical data from human brain autopsy studies and those from animal models point to an on going process of oxidative stress in the substantia nigra which could initiate dopaminergic neurodegeneration. It is not known whether oxidative stress is a primary or secondary event. Nevertheless, oxidative stress as induced by neurotoxins 6\u2010hydroxydopamine and MPTP (N\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine) has been used in animal models to investigate the process of neurodegeneration with intend to develop antioxidant neuroprotective drugs. It is apparent that in these animal models radical scavengers, iron chelators, dopamine agonists, nitric oxide synthase inhibitors and certain calcium channel antagonists do induce neuroprotection against such toxins if given prior to the insult. Furthermore, recent work from human and animal studies has provided also evidence for an inflammatory process. This expresses itself by proliferation of activated microglia in the substantia nigra, activation and translocation of transcription factors, NF \u03ba\u2010\u03b2 and elevation of cytotoxic cytokines TNF\u03b1, IL1\u2010\u03b2, and IL6. Both radical scavengers and iron chelators prevent LPS (lipopolysaccharide) and iron induced activation of NF \u03ba\u2010B. If an inflammatory response is involved in Parkinson's disease it would be logical to consider antioxidants and the newly developed non\u2010steroid anti\u2010inflammatory drugs such as COX2 (cyclo\u2010oxygenase) inhibitors as a form of treatment. However to date there has been little or no success in the clinical treatment of neurodegenerative diseases per se (Parkinson's disease, ischemia etc.), where neurons die, while in animal models the same drugs produce neuroprotection. This may indicate that either the animal models employed are not reflective of the events in neurodegenerative diseases or that because neuronal death involves a cascade of events, a single neuroprotective drug would not be effective. Thus, consideration should be given to multi\u2010neuroprotective drug therapy in Parkinson's disease, similar to the approach taken in AIDS and cancer therapy.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb06192.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T17:07:12Z","timestamp":1279645632000},"page":"262-273","source":"Crossref","is-referenced-by-count":73,"title":["Neuroprotective Strategies in Parkinson's Disease Using the Models of 6\u2010Hydroxydopamine and MPTP<sup>a<\/sup>"],"prefix":"10.1111","volume":"899","author":[{"given":"EDNA","family":"GR\u00dcNBLATT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SILVIA","family":"MANDEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MOUSSA B.H.","family":"YOUDIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0197-52"},{"key":"e_1_2_6_3_2","first-page":"24","article-title":"Oxidative mechanisms in nigral cell death in Parkinson's disease","volume":"13","author":"Jenner P.","year":"1998","journal-title":"Mov. Disord. Suppl."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb09150.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63030793.x"},{"key":"e_1_2_6_6_2","first-page":"259","article-title":"The neurotoxicity of iron and nitric oxide","volume":"60","author":"Youdim M.B.H.","year":"1993","journal-title":"Relevance to the etiology of Parkinson's disease. Adv. Neurol."},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(94)90055-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6_Suppl_3.161S"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"Olanow C.W.et al.1996. Iron and neurodegeneration: prospects for neuroprotection.InNeurodegeneration and Neuroprotection in Parkinson's Disease. C.W. Olanowet al. Eds.:55\u201369. London Academic Press.","DOI":"10.1016\/B978-012525445-8\/50006-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0031-6997(25)06677-3","article-title":"Pharmacological action of 6\u2010hydroxydopamine","volume":"26","author":"Kostrzewa R.M.","year":"1974","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.14.4546"},{"key":"e_1_2_6_12_2","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP\u2010induced parkinsonism","volume":"60","author":"Chiueh C.C.","year":"1993","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(79)90006-4"},{"key":"e_1_2_6_14_2","first-page":"2447","article-title":"The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6\u2010hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen G.","year":"1974","journal-title":"J. Biochem."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66052004.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-6842-4_7"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)01034-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(92)90151-6"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890110410"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb03384.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60867-4"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689592"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90508-8"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90746-3"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12706-3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870080102"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","unstructured":"Randall B.L. 1992. Iron aging and human disease: historical background and new hypotheses.InIron and Human Disease. B.L. Randall Ed.:1\u201323. CRC Press.","DOI":"10.1201\/9781351073899-1"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90833-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90857-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/10715769009109678"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110305"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01291883"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64041703.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90102-3"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91611-9"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01291884"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)11158-F"},{"key":"e_1_2_6_38_2","first-page":"3935","article-title":"The neostriatal mosaic: III","volume":"7","author":"Gerfen C.R.","year":"1987","journal-title":"Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb24523.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(92)90033-8"},{"key":"e_1_2_6_41_2","first-page":"329","article-title":"Inhibition of mitochondrial complexes I and IV by 6\u2010hydroxydopamine","volume":"292","author":"Glinka Y.Y.","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90705-7"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/311467a0"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870080506"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68020732.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00911-6"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91530-8"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(92)90142-K"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130208"},{"key":"e_1_2_6_50_2","first-page":"57","article-title":"Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6\u2010hydroxydopamine induced neurotoxicity","volume":"55","author":"Gr\u00fcnblatt E.","year":"1999","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6"},{"key":"e_1_2_6_52_2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine\u2010induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan D.","year":"1998","journal-title":"FASEB J."},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(87)91089-8"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.10.4565"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199512000-00016"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62010134.x"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90462-6"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90512-1"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(96)00020-8"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb11444.x"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1997.tb00390.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb06432.x"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1994.1187"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320718"},{"key":"e_1_2_6_65_2","first-page":"123","article-title":"Blood to brain iron uptake in one rhesus monkeys using [Fe\u201052]\u2010citrate and positron emission tomography (PET): influence of haloperidol","volume":"43","author":"Leender S.K.L.","year":"1994","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_2_6_66_2","unstructured":"Youdim M.B.H.et al.1999. Neuroprotective strategies in Parkinson's disease and Huntington Chorea: MPTP and 3\u2010NP induced neurodegeneration as models.InMitochondrial Inhibition and Neurodegenerative Disorders. P.R. Sandberg H. Nishino & C.V. Borlongan Eds. NewYork. Humana Press. In Press."},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02252926"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.65020923.x"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(92)90144-C"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0708"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1999.tb03267.x"},{"key":"e_1_2_6_72_2","first-page":"895","article-title":"Relationship between rate and extent of catechin absorption and plasma antioxidant status","volume":"46","author":"Pietta P.","year":"1998","journal-title":"Biochem. Mol. Biol. Inter."},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(96)00474-0"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-7508-8_21"},{"key":"e_1_2_6_75_2","first-page":"25","article-title":"Vitamin E and other endogenous antioxidants in the central nervous system","volume":"1","author":"Vatassery G.T.","year":"1998","journal-title":"Geriatrics."},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71041635.x"},{"key":"e_1_2_6_77_2","first-page":"703","article-title":"Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor","volume":"9","author":"Finberg J.P.","year":"1998","journal-title":"Neuroprotection"},{"key":"e_1_2_6_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120404"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00291-9"},{"key":"e_1_2_6_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.11.4078"},{"key":"e_1_2_6_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.3.791"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<122::AID-SYN3>3.0.CO;2-G"},{"key":"e_1_2_6_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12323-5"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90766-M"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.14.7531"},{"key":"e_1_2_6_86_2","first-page":"G1355","article-title":"Role of iron in NF\u2010kappa \u03b2 activation and cytokine gene expression by rat hepatic macrophages","volume":"272","author":"Lin M.","year":"1997","journal-title":"Am. J. Phys."},{"key":"e_1_2_6_87_2","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/j.1460-2075.1991.tb07761.x","article-title":"Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF\u2010\u03ba\u03b2 transcription factor and HIV\u20101","volume":"10","author":"Schreck R.","year":"1991","journal-title":"EMBO J."},{"key":"e_1_2_6_88_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.5.1181"},{"key":"e_1_2_6_89_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1620"},{"key":"e_1_2_6_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.4.1498"},{"key":"e_1_2_6_91_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.2.561"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)12192-7"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11686-Q"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.132.4.1497"},{"key":"e_1_2_6_95_2","first-page":"245","article-title":"Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription","volume":"49","author":"Tatton W.G.","year":"1997","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_2_6_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12961-X"},{"key":"e_1_2_6_97_2","first-page":"23","article-title":"Melatonin is protective against MPTP\u2010induced striatal and hippocampal lesions","volume":"60","author":"Acuna\u2010Castroviejo D.","year":"1997","journal-title":"Life Sci."},{"key":"e_1_2_6_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<593::AID-JNR9>3.0.CO;2-4"},{"key":"e_1_2_6_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1998.tb00371.x"},{"key":"e_1_2_6_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00689-6"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb06192.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb06192.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T04:42:46Z","timestamp":1740285766000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb06192.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb06192.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06192.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}